Medicaroid Corporation and Medicaroid Asia Pacific have announced the receipt of regulatory approval from the Health Sciences Authority in Singapore for the hinotori Surgical Robot System.
This approval marks an important step forward for the adoption of this robotic-assisted surgical system in Singapore’s healthcare landscape.
The hinotori is a robotic-assisted surgery system manufactured in Japan. It obtained regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) in August 2020. Since its introduction, it has been deployed in various medical institutions, and the number of surgical cases performed using this system has surpassed 2,000.
In Singapore, the hinotori Surgical Robot System will be employed in urology, gastroenterology, and gynaecology, as these procedure types have also received approval in Japan.
Medicaroid, through its medical robotics solutions, will support society where all patients, their families, and healthcare professionals can lead lives with a sense of assurance and tranquillity.